Subscribe

What are you looking for?

Main Menu

明報新聞網

中慧生物：四價流感病毒亞單位疫苗獲藥監新藥申請批准

Future Wealths
Future Wealths
13 8 月, 2025
One Min Read
8 Views
0 Comments
中慧生物－Ｂ(2627)公布，集團的商品名為慧爾康欣的四價流感病毒亞單位疫苗於2023年5月獲得中國國家藥品監督管理局的新藥申請(NDA)批准。

原文: https://finance.mingpao.com/fin/instantf/20250813/1755046855846/%e4%b8%ad%e6%85%a7%e7%94%9f%e7%89%a9-%e5%9b%9b%e5%83%b9%e6%b5%81%e6%84%9f%e7%97%85%e6%af%92%e4%ba%9e%e5%96%ae%e4%bd%8d%e7%96%ab%e8%8b%97%e7%8d%b2%e8%97%a5%e7%9b%a3%e6%96%b0%e8%97%a5%e7%94%b3%e8%ab%8b%e6%89%b9%e5%87%86

Last Update: 13 8 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept